Transplantation Proceedings
Volume 33, Issue 5, Supplement 1 , Pages S32-S39 , August 2001

Clinical impact and health economic consequences of posttransplant type 2 diabetes mellitus

  • J.B Chilcott

      Affiliations

    • School of Health and Related Research, Sheffield, UK (J.B.C., S.M.W.)
    • Corresponding Author InformationAddress reprint requests to Dr James B. Chilcott, School of Health and Related Research, Regent Court, 30 Regent Street, Sheffield S1 4DA, UK
    • ,
  • S.M Whitby

      Affiliations

    • School of Health and Related Research, Sheffield, UK (J.B.C., S.M.W.)
    • ,
  • R Moore

      Affiliations

    • University Hospital of Wales, Cardiff, UK (R.M.)

References 

  1. Hariharan S, Johnson CP, Bresnahan BA, et al.  N Engl J Med. 2000;342:605
  2. Arner P, Gunnarsson R, Blomdahl S, et al.  Diab Care. 1983;6:23
  3. Weir MR, Fink JC. Am J Kidney Dis. 1999;34:1
  4. Roth D, Milgrom M, Esquenazi V, et al.  Transplantation. 1989;47:278
  5. Boudreaux JP, McHugh L, Canafax DM, et al.  Transplantation. 1987;44:376
  6. Markall MS. Adv Renal Repl Ther. 2001;8:64
  7. Mayer AD, Dmitrewski J, Squifflet JP, et al.  Transplantation. 1997;64:436
  8. Pirsch JD, Miller J, Deierhoi MH, et al.  Transplantation. 1997;63:977
  9. Vincenti F, Laskow DA, Neylan JF, et al.  Transplantation. 1996;6:1576
  10. Centers for Disease Control and Prevention: Diabetes Surveillance, 1997. Atlanta, Georgia: US Department of Health and Human Services; 1997
  11. Miles AMV, Sumrani N, Horowitz R, et al.  Transplantation. 1998;65:380
  12. Sumrani NB, Delaney V, Ding Z, et al.  Transplantation. 1991;51:343
  13. Ojo AO, Hanson JA, Leichtman AB, et al.  Kidney Int. 2000;57:307
  14. Rubin RJ, Altman WM, Mendelson DN. J Clin Endocrinol Metab. 1994;78:809A
  15. Diabetes Control and Complications Trial Research Group . Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial. JAMA. 1996;276:1409
  16. Eastman RC, Javitt JC, Herman WH, et al.  Diab Care. 1997;20:725
  17. Eastman RC, Javitt JC, Herman WH, et al.  Diab Care. 1997;20:735
  18. Palmer AJ, Weiss C, Sendi PP, et al.  Diabetologia. 2000;43:13
  19. Department of Health, England: Hospital Episode Statistics— 1999/00. Available: http://www.doh.gov.uk/hes/standard data/index.html (accessed April 2001)
  20. Health Survey for England: In Evans B, Primatesta P (eds): Cardiovascular Disease 1998. Volume 1. Findings. London: HMSO
  21. UK Renal Registry The Second Annual Report of the UK Renal Registry. Available: http://www.renalreg.com (accessed March 2000)
  22. Klein R, Klein BE, Moss SE, et al.  Arch Ophthalmol. 1989;107:244
  23. Humphrey LL, Ballard DJ, Frohnert PP, et al.  Ann Intern Med. 1989;111:788
  24. Ballard DJ, Humphrey LL, Melton LJ, et al.  Diabetes. 1988;37:405
  25. Cecka JM: In Terasaki P (ed): Clinical Transplants 1990. Los Angeles, California: UCLA Tissure Typing Laboratory, 1990
  26. Vesco L, Busson M, Bedrossian J, et al.  Transplantation. 1996;61:1475
  27. 1999 Annual Report of the US Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data 1989–1998. Rockville, Maryland: HHS/HRSA/OSP/DOT. Available http://www.unos.org/Data/anrpt_main.htm (Accessed: March 2001).
  28. Humphrey LL, Palumbo PJ, Butters MA, et al.  Arch Intern Med. 1994;154:885
  29. Dyck PJ, Kratz KM, Karnes JL, et al.  Neurology. 1993;43:817
  30. Kannel WB, D’Agostino RB, Wilson PW, et al.  Am Heart J. 1990;120:672
  31. Anderson KM, Odell PM, Wilson WF, et al.  Am Heart J. 1991;121:293
  32. National Statistics: Mortality Statistics: Cause. Review of the Registrar General on Death by Cause, Sex and Age in England and Wales, Series DH2 No. 26. London: HMSO
  33. UK Prospective Diabetes Study Group: Cost effectiveness analysis of improved blood pressure control in hypertensive patients with Type 2 diabetes UKPDS 40. BMJ 317:720, 1998
  34. Moore R. International Congress and Symposium Series 217. London: Royal Society of Medicine Press; 1997;
  35. Chilcott J, Corcoran M, Rigg KM, et al: Tacrolimus and Mycophenolate Mofetil as Maintenance Immunosuppressants following Guidance Note for Purchasers. Renal Transplantation. Sheffield, UK: Trent Institute for Health Services: Research; 1999
  36. NHS Executive: The New NHS—2000 National Schedule of Reference Costs (http://www.doh.gov.uk/nhsexec/refcosts.htm)
  37. Michaels J, Brazier J, Palfreyman S, et al: Health Technol Assess 4, 2000
  38. Cosio FG, Pesavento TE, Osei K, et al.  Kidney In. 2001;59:732
  39. UK Prospective Diabetes Study Group . BMJ. 1998;316:823
  40. Diabetes Control and Complications Trial Research Group . N Engl J Med. 1993;329:977
  41. Jindal RM. Transplantation. 2000;70:5558

PII: S0041-1345(01)02233-3

Transplantation Proceedings
Volume 33, Issue 5, Supplement 1 , Pages S32-S39 , August 2001

Article Tools

* Image Usage & Resolution